ALISON BAKER: Open Payments
NPI 1528710274 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 64 payments from 14 companies in 2025. Trend: 2023 $1,450 · 2024 $2,155 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $280 |
| Vanda Pharmaceuticals Inc. | 8 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $202 |
| Alkermes, Inc. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 4 | $117 |
| Lundbeck LLC | 5 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Tris Pharma Inc | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, ARISTADA, TRINTELLIX, Dyanavel XR, COBENFY.
Industry payments across CO — which companies pay providers there.
